Stock Article
Stock Article
Microvision (MVIS) receives Purchase Order for More than $40M
Microvision, Inc. (NASDAQ:MVIS) has traded as high as $2.85 during today’s trading session and last traded at $2.65 for a gain of 38.74% from yesterday’s close. MVIS shares have traded as high as $12.40 over the past 52 weeks, which is over 78.62% off that high at last traded stock price. Read more
Stock Article
AGR Tools (AGRT) to Acquire 80% of 700 acre Paul Lease
Stock Article
Cell Therapeutics (CTIC) Institutional Investor to Purchase $40M in Stock
Cell Therapeutics, Inc. (NASDAQ:CTIC) has traded as high as $.93 during today’s trading session and last traded at $.92 for a gain of 1.49% from Friday’s close. CTIC shares have traded as high as $2.31 over the last 52 weeks and the stock is currently 60.17% off that high. Read more
Stock Article
Domark International (DOMK) preparing First Shipment of Solapads
Domark International Inc (OTC:DOMK) has traded as high as $3.45 during today’s trading session and last traded at the high for a gain of 21.91% from yesterday’s close and exactly 200% from my 4.24 alert! DOMK shares have traded as high as $4.88 over the past 52 weeks, which is 29.3% off that high at last traded stock price. Read more
Stock Article
Motricity (MOTR) introduces New Corporate Incentive Plan for 2012
Motricity, Inc (NASDAQ:MOTR) has traded as high as $.81 during today’s trading session and last traded at $.78 for a gain of 19.42% from yesterday’s close. MOTR shares have traded as high as $9.95 over the past 52 weeks, which is 92.16% off that high at last traded stock price. Read more
Stock Article
Medical Device Stock in Focus; MELA Sciences (MELA)
MELA Sciences, Inc.(NASDAQ:MELA) has traded as high as $3.12 during today’s trading session and last traded at $2.94 for a gain of 17.6% from yesterday’s close… MELA shares have traded as high as $6.96 over the past 52 weeks, which is 57.75% off that high at last traded stock price. Read more
Stock Article
Viral Genetics (VRAL) to commence Human Trials after New Drug passes FDA
Trader's Edge
Testimonials
The Preacher's alerts continue to amaze me! I have made money on almost ALL of his alerts since joining his free newsletter. His insight and commentary on the market is second to NONE! Thanks Preacher! Jonathan - Lansing, MI
After following a few of your recent Stock Profiles, I can see the potential for some very nice returns in the market... I can't wait until your next Profile comes out! Thank you, and please keep me updated. Steve - Houston, TX
I will admit that after reading your newsletter, my eyes are WAY MORE OPEN! I now have a way better understanding of how the markets work, and when I speak to my broker, I actually understand what he's talking about :) Thank you very much! Maria - Los Angeles, CA
Stock Preacher: your alerts have made me REAL money! Thanks for all the tips and insight that you've given to me and my partners! We can't imagine trading the markets without being a part of your newsletter! Preach on! Walter H. - Everett, WA


